Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$432/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Globe Newswire News Releases

May 06, 2024 07:22 ET
Allot Announces the Appointment of Eyal Harari as Chief Executive Officer
Allot Ltd. (NASDAQ: ALLT, TASE: ALLT), a leading global provider of innovative network intelligence and security solutions for service providers and enterprises worldwide, today announced the appointment of Eyal Harari as its Chief Executive...
May 06, 2024 07:15 ET
Flow Capital Announces Repayment of USD 4.5 Million Investment
Flow Capital Corp. (TSXV: FW) ("Flow Capital"), a leading provider of flexible growth capital solutions, is pleased to announce the full repayment of a USD 4.5 million investment in an environmental solutions provider. Flow Capital continues to...
May 06, 2024 07:15 ET
SAB Biotherapeutics Appoints Jay Skyler, MD, to the Board of Directors
SAB Biotherapeutics (Nasdaq: SABS) (the “Company” or “SAB”), a clinical-stage biopharmaceutical company with a novel immunotherapy platform developing a human anti-thymocyte immunoglobulin (hIgG) for delaying the onset or progression of type 1...
May 06, 2024 07:13 ET
N2OFF: Save Foods to Target California’s Hemp Market
N2OFF, Inc.\ (NASDAQ: NITO) (FSE:80W) (“N2OFF” or the “Company”), a pioneer agri-food tech company offering sustainable solutions for agriculture and plant-based food, announced today that its subsidiary Save Foods Ltd. (“Save Foods”) is set to...
May 06, 2024 07:12 ET
Skyward Specialty Announces Secondary Offering of Its Common Stock
Skyward Specialty Insurance Group, Inc. (NASDAQ: SKWD) (“Skyward Specialty” or the “Company”) a leader in the specialty property and casualty (“P&C”) market, announced that The Westaim Corporation (“Westaim”), through its wholly-owned subsidiary,...
May 06, 2024 07:03 ET
Flash News: OKX Launches Cryptopedia Season 17 Campaign Featuring 6,666,666 Ultiverse Token Prize Pool
OKX, a leading Web3 technology company, has issued updates for May 6, 2024. OKX Launches Cryptopedia Season 17 Campaign Featuring 6,666,666 Ultiverse Token Prize Pool OKX today announced the launch of Season 17 of Cryptopedia, a learn-to-earn...
May 06, 2024 07:01 ET
Stellantis Pro One Achieves No. 1 Spot in Middle East & Africa Region and Strengthens Commercial Vehicle Leadership in Europe and South America
Stellantis Pro One Achieves No. 1 Spot in Middle East & Africa Region and Strengthens Commercial Vehicle Leadership in Europe and South America Achieves No. 1 spot with a record 26% market share in Middle East & Africa, led by strong performance in...
May 06, 2024 07:00 ET
BiomX to Present at the 2024 RBC Capital Markets Global Healthcare Conference
BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, today announced the company will participate in the RBC Capital...
May 06, 2024 07:00 ET
AMG Reports Financial and Operating Results for the First Quarter of 2024
AMG, a leading partner to independent investment management firms globally, today reported its financial and operating results for the first quarter of 2024. Jay C. Horgen, President and Chief Executive Officer of AMG, said:“In the first quarter,...
May 06, 2024 07:00 ET
Omega Therapeutics Reports First Quarter 2024 Financial Results and Highlights Recent Company Progress
Omega Therapeutics, Inc. (Nasdaq: OMGA) (“Omega”), a clinical-stage biotechnology company pioneering the development of a new class of programmable epigenomic mRNA medicines, today announced financial results for the first quarter ended March 31,...
May 06, 2024 07:00 ET
Agios to Present at the BofA Securities 2024 Health Care Conference on May 16, 2024
Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and PK activation pioneering therapies for rare diseases, today announced that the company is scheduled to present at the BofA Securities 2024 Health Care Conference on...
May 06, 2024 07:00 ET
Apellis Pharmaceuticals to Host a Fireside Chat at the Bank of America Securities Healthcare Conference
Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the company will host a fireside chat at the Bank of America Securities Healthcare Conference on Tuesday, May 14, 2024, at 8:00 a.m. PT. The live conference webcast will be posted...
May 06, 2024 07:00 ET
Axsome Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, today announced financial results for the first quarter of 2024. “The...
May 06, 2024 07:00 ET
BioCryst Reports First Quarter 2024 Financial Results and Provides Business Update
BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today reported financial results for the first quarter ended March 31, 2024, and provided a corporate update. “We are off to a fantastic start to the year with outstanding ORLADEYO revenue growth and...
May 06, 2024 07:00 ET
Brookfield Asset Management and Castlelake to Enter into Strategic Partnership
Brookfield Asset Management (NYSE: BAM, TSX: BAM) (“Brookfield”) and Castlelake L.P. (“Castlelake”), an alternatives asset manager specializing in asset-based private credit including aviation and specialty finance, today announced that they have...
May 06, 2024 07:00 ET
Cara Therapeutics to Announce First Quarter 2024 Financial Results on May 13, 2024
Cara Therapeutics, Inc. (Nasdaq: CARA), a development-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of patients suffering from pruritus, today announced the Company will report first quarter 2024 financial...
May 06, 2024 07:00 ET
CW Petroleum Corp (CWPE) Submits Application to List on OTCQB
CW Petroleum Corp (CWPE) (the “Company”), a leading provider of Specialty Renewable and Hydrocarbon Motor Fuels, today announced that it has applied with OTC Markets to list its security, CWPE, on the OTCQB Exchange. Chief Executive Officer...
May 06, 2024 07:00 ET
EyePoint Pharmaceuticals Announces Topline Data from the Phase 2 PAVIA Trial of DURAVYU™ in Non-Proliferative Diabetic Retinopathy
EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases, today announced topline results of its Phase 2 PAVIA clinical trial...
May 06, 2024 07:00 ET
Foghorn Therapeutics Provides First Quarter 2024 Financial and Corporate Update
Foghorn® Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression, today provided a financial and corporate update in conjunction...
May 06, 2024 07:00 ET
GXO to Manage Logistics Operations for Levi Strauss & Co at State-of-the-Art German Distribution Center
GXO Logistics, Inc. (NYSE: GXO), the world’s largest pure-play contract logistics provider, today announced a 20-year partnership agreement with Levi Strauss & Co (LS&Co.) to manage operations at a state-of-the-art 70,000 square meter Dorsten...